The Iliac/SFA/Popliteal Center

Filter Your Results




Boston Scientific Launches Mustang PTA Balloon Catheter

June 20, 2011—Boston Scientific Corporation (Natick, MA) announced the global launch of the Mustang percutaneous transluminal angioplasty (PTA) balloon catheter. The company…

Cook’s Zilver PTX Compares Favorably to PTA for SFA Treatment in Diabetic Patients

June 18, 2011—The Society for Vascular Surgery (SVS) announced that results of a prospective, randomized trial indicate that the Zilver PTX paclitaxel-eluting stent (Cook Me…

Boston Scientific Recalls Innova SFA Stent System in International Markets

June 17, 2011—The US Food and Drug Administration (FDA) has posted notification of a Class I recall that was initiated on May 19 of certain lots of the Innova over-the-wire …

IDev Completes Enrollment of SUPERB Trial

June 2, 2011—IDev Technologies, Inc. (Webster, TX) announced the completion of enrollment in the SUPERB trial, which is evaluating the use of the company’s Supera stent sy…

Access & Closure in Practice

May 2011—Experts from a variety of specialties answer questions about their daily choices in vascular access and closure.

Coding for Lower Extremity Revascularization in 2011

Katharine L. Krol, MD

May 2011—The codes describing endovascular procedures for lower extremity revascularization have been completely revised, effective January 1, 2011. This was done in response to req…

An Interview with Tony S. Das, MD

May 2011—To what degree does on-label status affect your decision making in terms of superficial femoral artery (SFA) stent choice? We have previously been more interested in perfor…

Long-Lesion Study Supports IDev’s Supera Stent to Treat SFA and Popliteal Disease

May 17, 2011—IDev Technologies, Inc. (Webster, TX) announced that data from a long-lesion study of 182 patients with significantly diseased superficial femoral arteries (SFA…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.